Source: MarketScreener

Acura Pharmaceuticals Inc: Acura Pharmaceuticals : Announces Third Quarter 2021 Financial Results - Form 8-K

(marketscreener.com) Acura Pharmaceuticals, Inc. , an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications, announced today financial results for the three and nine months ended September 30, 2021. The Company reported revenues of $270...https://www.marketscreener.com/quote/stock/ACURA-PHARMACEUTICALS-IN-120789192/news/Acura-Pharmaceuticals-Announces-Third-Quarter-2021-Financial-Results-Form-8-K-37059902/?utm_medium=RSS&utm_content=20211117

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
Robert B. Jones's photo - President & CEO of Acura Pharmaceuticals Inc

President & CEO

Robert B. Jones

CEO Approval Rating

85/100

Read more